IGRA (interferon gamma release assay)
Revvity Gains FDA Approval for Automated Latent TB Test
The firm said that it has received approval for a test that combines the Allsheng-developed Auto-Pure 2400 liquid handling platform with Revvity's T-SPOT.TB test.
Qiagen Sues BioMérieux in German Court for Infringing Tuberculosis Test Patent
Qiagen alleges that BioMérieux infringes a European patent that protects the company's QuantiFeron interferon-gamma release assay technology for latent TB detection.
German Patent Court Upholds Qiagen Patent Suit Against SD Biosensor
Qiagen said the intellectual property in question covers technologies used in its QuantiFeron latent tuberculosis assays.
DiaSorin Submits Lyme Disease Test for FDA Approval
The Liaison LymeDetect chemiluminescent immunoassay, developed in partnership with Qiagen, detects Borrelia burgdorferi infection.
PerkinElmer's Oxford Immunotec Gains FDA Go-Ahead for TB Test Automation
The PerkinElmer subsidiary said its T-Cell Select reagent kit reduces hands-on lab work and cost and simplifies blood sample storage.
Jan 7, 2021
PerkinElmer to Buy Oxford Immunotec for $591M
May 5, 2020
Oxford Immunotec Q1 Revenues Fall 6 Percent
Nov 5, 2019
Oxford Immunotec Q3 Revenues Grow 32 Percent
Aug 6, 2019
Oxford Immunotec Q2 Revenues Jump 18 Percent
May 9, 2019